Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ -29,208
▼ 222% vs 2024
Profit
Caution€ -2.3 million
▼ 15% vs 2024
Debts
Low€ 693,714
▼ 51% vs 2024
Cryotherapeutics from Ans, company number BE0713882584, closed financial year 2025 with a result of € -2.3 million after tax. For that financial year Cryotherapeutics recorded a gross margin of € -29,208 and equity of € 21.1 million. Compared with financial year 2024, the result moved from € -2 million to € -2.3 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.
What happened at Cryotherapeutics?
What happened at Cryotherapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Yiannakis YIANNI stepped down as director. NBB
- NOSHAQ Partners SCRL stepped down as director. NBB
- NRW BANK stepped down as director. NBB
- Chen Yen-Fu stepped down as director. NBB
- Peppermint Venture Partners GMBH stepped down as director. NBB
- Christine RAINER stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2.3 million. Source: NBB ↗
- Yiannakis YIANNI became a director. NBB
In short
From € 1 million loss in 2021 to € 2.3 million loss in 2025.
On average € 2,400 of value added per employee in 2024.
A new publication or filing at Cryotherapeutics? We notify you, reason included.
Follow CryotherapeuticsNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of Cryotherapeutics GmbH itself.
Directors
According to the 2025 annual accounts
Yiannakis YIANNI
Managing director
since 2025 · until 2028
Director · represented by Eric BRANDT
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE +174 more
since 2025 · until 2028
NRW BANK
Director · represented by Florian STINAUER
since 2025 · until 2028
Chen Yen-Fu
Director
since 2025 · until 2028
Peppermint Venture Partners GMBH
Director · represented by Joachim RAUTTER
since 2025 · until 2028
Christine RAINER
Director
since 2025 · until 2028
Establishments
Establishment units
Physical locations of this company
Avenue Alfred Deponthière 46 box 21
4431 Ans
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
CLOUDFLARESPECTRUM Cloudflare, Inc., US
DNS
OVH DNS
Domain
Domain
cryotherapeutics.com
Registered
2005-03-01
Registrar
OVH sas
Expires
2027-03-01
Website info
Features
Security
Details
- Company number
- 0713.882.584
- VAT number
- BE 0713.882.584
- Registered office
- Avenue Alfred Deponthière 46 bus 21, 4431 Ans
- Names & denominations
- Cryotherapeutics
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 26 November 2018
- Peppol
- Active · Active since 16 Sept 2025
- Contact
- cryotherapeutics.com
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Vervaardiging van overige farmaceutische producten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Detailhandel in farmaceutische producten